Search Results For ''

  • Immuron enrols first patients into Phase 2 trials for treatment to combat infectious diarrhea

    Infectious diarrhea could soon be not so infectious with confirmation from biotech company Immuron (ASX: IMC) that the first patients have enrolled for their Phase 2 clinical trial seeking to address issues that arise from unpleasant episodes.  The trial is a response to the persistent challenge of infectious diarrhea among travellers and military personnel deployed

    Read More
    Public
  • Are we in the eye of the inflation storm? | Economic update

    During November the market consensus shifted towards the FOMC and ECB remaining on hold throughout 2024. This reflects a forecast that inflation will continue to deflate while unemployment remains low, and the economy keeps growing but at a slow pace. This is the “Goldilocks” scenario. The alternative view is that inflation will begin to rise

    Read More
    Public
  • Fragrances to treat allergies? Microba and IFF enter stage two of novel treatments

    Precision microbiome company Microba (ASX: MAP) and the US-based F&B company International Flavors & Fragrances (IFF) have entered the second phase of their joint research initiative, aiming to develop novel microbiome-based treatments for various allergies. The collaboration, a strategic move within the bioscience and health sectors, signals a step forward in addressing the need for

    Read More
    Public
  • RAS Technology dives deeper into European wagering with Playbook Engineering partnership

    Quickly becoming the go-to supplier of critical data within the global wagering industry, RAS Technology (ASX: RTH) has been engaged by Playbook Engineering, a leading UK-based platform provider, for wagering technology, racing data, and editorial content for Playbook’s diverse portfolio of sportsbook brands. The 3-year contract is expected to be valued at $800k per annum

    Read More
    Public
  • BluGlass signs $2.6 million contract with North Carolina State Uni to develop lasers

    After becoming a member of the US CLAWS hub in October 2023, semiconductor developer BluGlass (ASX: BLG) has signed its first contract: a $2.6 million (US$1.775m) contract with North Carolina State University (NCSU) to develop lasers in FY24.  As part of its contract for FY24, BluGlass is working on single-frequency DFB (Distributed-feedback) lasers and progressing

    Read More
    Public
  • Markets continue to push higher as Powell signals peak rates

    The XJO is expected to open higher this morning following a strong night in the U.S on Friday. Their futures have also edged into the green. Over the past few sessions our market has been meekly rising, with Thursday’s strong day breaking the flag pattern (signalled by the break of the short-term descending channel). We

    Read More
    Public